Brief: Algernon Pharmaceuticals Appoints Dr. Walter Reinisch To Its Medical And Scientific Advisory Board
04/04/2019 12:11
April 4 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS APPOINTS LEADING INFLAMMATORY
BOWEL
DISEASE EXPERT DR. WALTER REINISCH TO ITS MEDICAL AND SCIENTIFIC
ADVISORY BOARD
Source text for Eikon: ID:nGNX8wwMbW
Further company coverage: AGN.CD
((Briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement